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Abstract

Background: Psychiatric illness is unpredictable, has spasmodic tendencies, and represents one
of the most reported types of disabilities in the United States. Behavioral health clinicians are
frontline responders and considered a major ally to providers by supporting medication
management recommendations and referring new patients for medication management. Basic
evidence-based psychopharmacology improves behavioral health clinicians’ knowledge,
however, is inadequate in curricula, and many undergraduate and graduate programs lack one
dedicated psychopharmacology class. This abbreviated knowledge contributes to inadequate
referrals for treatment and poor confidence in supporting the practitioners’ medication
recommendations.
Method: This project examined behavioral health clinicians’ knowledge, confidence, and
beliefs, and identified ways to influence positive clinical behaviors, primarily by optimizing
medication literacy through an educational session and resources for their use after the initial
session. In addition, the project compared referral rates before and after the educational session.
Results: This project validates evidence that optimizing clinicians’ medication knowledge
through a multi-modal faceted approach, in which practitioners facilitate education to
collaborative teams, improves confidence and positive beliefs and may contribute to increased
referral rates for medication management.
Conclusion: This project provided an educational session to behavioral health clinicians about
common mental health medications to determine if it would promote medication knowledge,
strengthen confidence, and influence positive belief systems. Additionally, it identified patterns
that may suggest accelerated referrals for medication management after expanded medication
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knowledge. Ultimately, it was anticipated that shared decision-making through a collaborative
approach can guide superior patient outcomes.
Keywords: psychopharmacology, therapist, behavioral clinician, mental health literacy,
outcomes, knowledge, confidence, beliefs
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Using an Educational Session to Improve the Knowledge, Confidence, and Beliefs about
Psychopharmacology for Behavioral Health Clinicians

Problem Description
The burden of mental health illness can have remarkable consequences on disability and
global costs. It is the leading cause of disability with over 400 million employee disability days
claimed and is associated with over 83 billion dollars annually in costs (CDC, 2015). Mental
health disorders are associated with the frequency, intensity, and resolution of several chronic
illnesses, such as cardiovascular disease, asthma, and obesity (CDC, 2015). Patient stability and
chronicity are always transforming because mental illness can fluctuate from mild to severe and
patients can experience mental health stability for months, even years, but abruptly suffer an
acute exacerbation that can require hospitalization. Outpatient mental health clinics are unique
since the range of patient diagnoses varies from depression and anxiety to personality disorders,
attention deficit disorders, schizophrenia, and bipolar disorder. Fifty-four percent of adult
Idahoans did not receive treatment for their mental health in 2013 (Behavioral Health Barometer,
2014), which emphasizes how crucial behavioral health clinicians are to connecting patients to a
provider.
Twenty-five percent of the people in the United States (U.S.) will experience some type
of mental health disorder in their lifetime (CDC, 2013). The disability consequences are
functional, emotional, and financial. Functional and emotional impairments are characterized by
defects in social and occupational elements of an individual’s life (Miklowitz, 2011). Financial
damages can result in patient loss of income and subsequently increased costs to the public. The
stigma of mental health illness can further discriminate against this population and lead to
perceived reduced quality of life. People with mental health issues have more absenteeism in the
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workplace and higher rates of unemployment (CDC, 2013). Nationally, the financial impact is
over 300 billion dollars in turnover, loss of productivity and unemployment costs (CDC, 2013).
Positive mental health is associated with improved health outcomes; these associations include
patient perception of stability, reduced provider visits, no admissions, and functional
productivity; however, only 17% of the population considers they are at their ideal mental health
(CDC, 2013).
Evidence supports the treatment of moderate to severe cases of mental health illnesses
with medications but combining psychotherapy (cognitive-behavioral counseling and other nonmedication treatment of mental health illnesses) can provide superior results compared to
medications alone. The combination can expedite remission and impart lifelong techniques to
reduce the risk of relapse of symptoms once off medications (Feros et. al, 2010).
Psychopharmacology is considered a standard component of mental health care, and frequently
co-occurs with psychotherapy.
Behavioral health clinicians or “clinicians are collaborators in the mental health setting
and see patients more frequently than medication prescribers. They provide psychotherapy (i.e.
marital, family, and individual treatment) to improve their client’s ability to function with others,
socially and mentally. In addition, they provide drug and alcohol treatment to develop sobriety
and improve the length of remission. Clinicians, however, do not have prescriptive authority or
educational preparation in pharmacology and must be allied with medication providers to support
psychopharmacology recommendations and improve appropriate referrals. Skilled clinicians
must discern subtle clues that can indicate changes in symptoms, such as possible need for
referral to a medication provider or problems with the current medication regimen, in order to
prevent full relapse of mental health illness. The ability of clinicians to respond appropriately,
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however, to these important cues is influenced by their knowledge, beliefs, and confidence
regarding psychopharmacology (Springer & Harris, 2010). Psychopharmacology deficits
translate into clinicians’ inability to identify the severity of mental illness that may require
medication management, thus resulting in inadequate referrals and substandard recognition of
disease processes. Negative clinician beliefs about psychopharmacology can unknowingly
surface as unchecked biases, in which clinicians deter patients in seeking medication
management and fail to support the practitioner’s recommendations. Poor clinician confidence
associated with psychopharmacology familiarity can obstruct collaboration between patient and
practitioner because they lack self-assurance regarding their ability to support and discuss
medication management issues.
Knowledge and attitudinal barriers can inadvertently be directed to mental health
patients who seek reassurance or guidance about efficacy and the necessity of their provider’s
medication recommendation. If the patient gauges that the clinician has a negative response to
medications (influenced by lack of knowledge), adherence or a referral could be affected (Feros
et al., 2010). Educational programs in the workplace can improve behavioral health clinicians’
knowledge, confidence, and beliefs, which can ultimately generate improved patient outcomes.
It is essential to incorporate evidence-based pharmacologic instruction to develop astute,
supported, and trained clinicians to promote improved patient outcomes and improve the global
financial burden. Therefore, the purpose of the project was to describe whether a
psychopharmacology educational session, medication resources, and consultation with a
provider, improved clinician’s knowledge, confidence, and beliefs about psychopharmacology
management, and improved referral rates for medication management.
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Available Knowledge
The PICO question was: Do behavioral health clinicians in an outpatient mental health
clinic (P) have improved knowledge, confidence, and beliefs about psychopharmacology
management (O) when provided with a basic psychopharmacology educational session and
resources? The PICO question guided the search terms. A literature search was completed using
four computerized databases: CINAHL, PsychINFO, ERIC, PubMed. Search terms were
selected to extract information precisely relevant to the PICO question and included
psychopharmacology, therapist, behavioral clinician, mental health literacy, outcomes,
knowledge, confidence, beliefs, pharmacology practice guidelines, APNs and collaborative care.
The total number of articles obtained from these databases was 294. The number appropriate for
review was 57, but 34 were selected for specificity and applicability (see Appendix A for Table
of Evidence).
The articles that were reviewed discussed barriers that may interfere with clinician
recognition of mental health diseases, screening for medication management, medication
educational interventions, medication knowledge and experience, and the relationship to
confidence, beliefs, and knowledge, applying gold-standard testing and treatment, organizational
constraints, mental health outcomes, and the evidence for using current clinical guidelines to
direct practice. Four of the studies helped to define current clinical practice guidelines for
screening mental health illnesses and influencing other clinicians through the application of these
guidelines used in practice (Bentley & Kogut, 2008; Cohen, 2002; Graham, James, & Cowan,
2000; Kates & Mach, 2007;). Eight studies addressed the deficiency of psychopharmacology in
clinician programs, tailoring educational programs to improve behaviors toward
psychopharmacology, efficacy of educational sessions, and compared levels of medication
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knowledge and specific educational concept models that improve clinician knowledge and
confidence (Burgermeister, Kwasky, & Groh, 2011; Haddad et al., 2015; Hughes & Cohen,
2010; Moses & Kirk, 2006; Osborn et al., 2013; Shirazi et al., 2009; Thompson et al., 2000;
Vincente et al., 2007). Eleven articles investigated clinician knowledge, confidence, and beliefs
in treating mental health disorders (Baik et al., 2008; Bride et al., 2013; Burgermeister et al.,
2011; Byrne et al., 2004; Casini et al., 2013; Feros et al., 2010; Hemingway et al., 2014; Liu et
al., 2008; Naji et al., 2004; Rice et al., 2010; Shirazi et al., 2009). Three articles provided
screening guidelines to improve recognition of mental health illness, reinforcement of EBP
recommendations, screening tools that can contribute to EBP referrals for medication
management, and screening scales to measure clinician’s knowledge, confidence, and beliefs
(Babor, Walsh, & Rosemary, 2007; O'Connor, 2009; Sui, 2016). Finally, three articles discussed
medication referral criteria, influencing factors for referring appropriately for medication
management, knowledge foundation and likelihood to refer, and attitudes that can conflict with
referral practices (Dziegielewski & Leon, 1998; Farinde, 2014; Springer & Harris, 2010; Stern et
al., 1999).
Suggestions from the Literature
The surveyed articles were published from 1998 to 2016 and the years of publication
were extended to improve interpretation and dissemination of results. Despite significant preexisting evidence that suggests that the use of EBP guidelines improves mental health outcomes,
there is minimal data to evaluate the knowledge, confidence, and beliefs of clinicians,
specifically behavioral health clinicians. Subsequently, the major limitation of these studies was
the absence of evidence addressing clinician knowledge, confidence, and beliefs in relation to
psychopharmacology; however, high-quality research studies exist on general practitioners’
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qualities, which may be applicable to clinicians on a more basic level. Overall limitations and
weaknesses were low sample size, lack of educational recommendations that improve outcomes,
lack of a pragmatic evidence base, homogeneity, short-term RCT trials, attrition, low response
rates, and the inability to acknowledge the full role of clinical behaviors and variables in the
education delivered (Baik et al., 2008; Casini et al., 2013; Hemingway et al., 2014; Liu et al.,
2008; Shirazi et al., 2009;). The particular strength in these research articles is the large body of
evidence that supports clinician insecurity with psychopharmacology, inadequate
psychopharmacology knowledge, and how core beliefs can affect practice decision-making.
Optimizing psychopharmacology education can improve clinician knowledge, confidence, and
beliefs (Casini et al., 2013; Hemingway et al., 2013; Shirazi et al., 2009).
While there is already pre-existing research and evidence that supports the use of
evidence-based psychopharmacology principles in practice, the research articles provide an
argument that ambivalent clinician beliefs and confidence may influence patient receptivity,
adherence, and decision-making about medications. Improving psychopharmacology literacy
can produce positive clinical behaviors towards a provider’s medication recommendations and
promote positive influences on EBP clinical decision-making (Hemingway, Rogers, & Elsom,
2014). This may ultimately cultivate improved mental health outcomes in patients in the longterm. More research is required to understand what educational interventions would improve not
only clinicians’ clinical behaviors, but also mental health outcomes.
This synthesis gives direction for future foci and offers early evidence-based implications
to the PICO question. Despite tangible evidence that EBP, if utilized, can improve patient
outcomes, it is clear that clinicians lack actual application in practice. This can be a result of
insufficient training, continuing education, or poor confidence and beliefs, which can impede
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application of EBP decisions. Further research needs to be directed at clinician specific
knowledge, beliefs, and educational interventions that can improve confidence while
encouraging management of mental health that is in line with gold-standard EBP
recommendations.
Rationale
A major component that can influence clinicians’ clinical behavior is the lack of
knowledge, confidence, and beliefs with psychopharmacology rationale and management
(Springer & Harris, 2010). Attitudinal barriers can inadvertently be directed to mental health
patients who seek reassurance or guidance about the efficacy and necessity of their provider’s
medication recommendation.
This assumption can positively influence clinic stakeholders by reinforcing the need for
the educational pilot program, encouraging engagement and motivation to participate. It was
anticipated that validating this assumption with the clinic owners and clinicians during the
program planning meetings would help strengthen participation. Another assumption is that
psychopharmacology training in the workplace can improve clinicians’ knowledge, confidence,
and beliefs, which can ultimately generate improved patient outcomes (Bee et al., 2008). This
assumption can be a positive one because the long-term goal of the project is to affect patient
mental health outcomes.
The Theory of Planned Behavior was developed by Ajzen (2001), who hypothesized that
behavior influences an individual’s intent to implement a behavior and intention is decided by
current attitudes, perceived behavioral control, and subjective norms (see Appendix B for Theory
of Planned Behavior). Educational information, that models positive beliefs and positive
attitudes, improves clinical confidence toward the proposed behavior and can increase the chance
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that it will be implemented in practice (Thompson-Leduc et al., 2014). The proposed project
identified clinicians’ knowledge and confidence about psychopharmacology and tailored an
educational session to improve those characteristics that follow and are supported by evidencebased research. The objective of applying these theories was to support improvement of
clinicians’ clinical behaviors to facilitate the initiation of positive knowledge, confidence, and
beliefs about psychopharmacology in practice. The desired end result is to establish a new
model of care built on evidence, thereby improving collaborative relationships with medication
providers, and improving clinical outcomes of patients receiving psychopharmacology.
Composing a logic model was necessary for this project and provided guidance and
information that was easily adaptable into future results and used to evaluate the success of
goals. A logic model can be translated and interpreted by all stakeholders and offers key
information about what outcomes are expected from the project (W.K. Kellogg Foundation
Logic Model Development Guide, 2006). Combining the logic model with the Theory of
Planned Behavior, as a foundation, allowed the DNP to influence positive behaviors by
improving attitudes, perceived behavioral control, and subjective norms. The outcomes in this
project were designed to follow the recommendations of this theory.
Specific Aims
The purpose of this scholarly project was to describe whether a psychopharmacology
educational session, medication resources, and consultation with a provider, improved clinicians’
knowledge, confidence, and beliefs about psychopharmacology management, and improved
referral rates for medication management. This project sought to improve attitudes that may be
impeding positive clinical behaviors, such as support of medication recommendations and
referrals for medication management, thus influencing outcomes for mental health patients. The
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doctoral nurse practitioner (DNP) student measured knowledge, confidence, and beliefs with preand post-questionnaires, before and after the initial educational session, and then again two
months later, to assess for changes in response and to determine whether any educational benefit
was retained. In addition, comparison of referral rates from before the educational session and
again two months after, was evaluated (see Appendix D for the project short-term outcomes).
Context
The population for this scholarly project included clinicians in three outpatient mental
health facilities. The proposed project originated in three mental health clinics in Meridian,
Nampa, and Boise, Idaho. All of the mental health clinics are clinician-owned, the medical
providers are contracted positions, and memorandums were obtained by each owner (see
Appendix F for memorandums). The three clinics offer a variety of services, including
individual psychotherapy, family psychotherapy, group therapy, day treatment, and
community-based therapy
All types of mental health conditions and chronicity are managed in the included
practices, including bipolar disorder, attention deficit disorder, depression, schizoaffective
disorder, schizophrenia, anxiety, post-depression disorder, behavioral disorders, and sleep
disturbances. The DNP student conducted a research review, developed an educational
intervention, implemented teaching, processed results, and disseminated the program to
instructors and cohorts. Although the DNP project is geared towards clinicians, the ultimate
goal of this project is to improve mental health.
There are inherent risks in all projects increase the potential of impeding the project’s
progress. Some risk factors for this project included not being able to engage clinicians to
participate, not convincing the clinics to invest time to train participants, access to live
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consultation, conflicts with clinician workloads, and the inherent complexity of
psychopharmacology data. Lack of engagement could lead to a smaller sample size and hinder
the opportunity to extract meaningful information. To prevent poor participation, the educational
session was conducted at monthly meetings. To improve the chances that clinics would allow
the use of meeting times to deliver the education, the plan included emphasis on costs savings
and patient benefits, both short and long-term.
The live resource was designed to be flexible so that each clinician who wanted
consultation could receive it. The laminated resource was placed conveniently on each desktop.
Prior to and after the educational session, clinic managers were given a summary of the key
differences in knowledge, confidence, and beliefs reflected in the pre-and postquestionnaires. To engage clinic manager involvement and acceptance of the project, positive
influential factors were emphasized, which can be used to strengthen the purpose and goals. It
was equally important to identify any factors that could potentially impact project goals
negatively (W. K. Kellogg Foundation Logic Model Development Guide, 2006).
The organizational culture of all three clinics was motivated by deficiencies in
psychopharmacology and a willingness to improve cooperation between providers and clinicians
in order to impact patient health outcomes. Prior to the start of the project, program planning
meetings with owners and clinicians clearly identified this need for education and support for the
project.
Interventions
The goal of this project was to develop a psychopharmacology educational program
tailored to clinicians to improve attitudinal responses towards medications management. The
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aim of the educational program was to engage positive clinical responses by improving the
knowledge, confidence, and beliefs of clinicians.
These short-term outcomes, as measured, were achieved during the pilot project:
•

Outcome 3: By August 2016, a demographic tool, knowledge, confidence, and beliefs
questionnaire, and follow-up resource questionnaire, will be created and ready for
implementation by May 2017.

•

Outcome 9: By July 2017, clinician scores on the knowledge questionnaire (time 2)
increased by 10% from baseline (time 1);

•

Outcome 10: By September 2017, clinician scores on the knowledge questionnaire (time
3) increased by 15% compared to the baseline questionnaire (time 1);

•

Outcome 11: By September 2017, there was a 10% increase in the three clinics’ database
for referrals for medication management, compared to referral rates before the
educational session; and

•

Outcome 12: By September 2017, of the 20 participants who received training, at least
20% used the resources evidenced by quantitative data from the resource follow-up
questionnaire 2017.
The development of short and long-term outcomes was a result of quality feedback from

clinicians and the involvement of 18 participants. The short-term outcomes were developed to
improve clinician knowledge, confidence, and beliefs in psychopharmacology management. The
long-term outcomes are intended to influence clinician intent to refer for medication
management and then also to improve patient mental health outcomes. It was anticipated that the
long-term outcomes would be accomplished within 3 to 5 years after the pilot project. For longterm outcomes refer to Appendix D.
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The first step in the intervention process focused on outcomes one and two of the
program, which assessed the clinicians’ needs by conducting program-planning groups and
obtaining memorandums of agreement from the three clinic owners. These planning groups
helped establish a foundation about what was most important for clinicians to know about
psychopharmacology and what educational interventions could be tailored to fit those needs.
Thus, the content of the educational session was based on feedback from clinic owners and
clinicians, and addressed the common antidepressants, antipsychotics, mood stabilizers,
anxiolytics, hypnotics, and stimulants (see Appendix H).
The next step was to obtain baseline referral rates for each of the three clinics from
February to April 2017. Data were collected for comparison, after the educational intervention
was completed. A welcome letter was given to the clinicians before starting the educational
session to explain the intent and purpose (see Appendix G). Participants completed baseline
demographic information (see Appendix J) and baseline (time 1) knowledge, confidence, and
beliefs questionnaires, since negative and positive responses can influence clinical behaviors (see
Appendices H & I).
An educational session constructed on basic EBP pharmacologic principles was offered
by face-to-face instruction during mandatory organizational monthly meetings. Each participant
attended only one educational session. Knowledge, confidence, and beliefs were tested after the
educational session with the same questionnaire given prior at baseline (time 2). After the
educational session, the clinicians had access to a variety of resources. First, a double-sided
laminated resource was given to participants upon completion of the questionnaires and
educational session. The resource included common medications, side effects, and indications.
This resource was loaded on the desktop of each clinician. In addition to the laminated resource,
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the clinicians had access to live one-hour open consultations per week, in which the DNP student
was available for telephone, email, or in-person consultation. The purpose of the open
consultation was to address any medication consultation needs, and to serve as an additional
resource for referrals or other questions. Participants were given the option of 15-minute time
slots within one-hour blocks each week. The one-hour open consultation was set up via private
(invite only) email. All participants were added to the email group and the DNP student sent out
the scheduled blocks of time. The participants could schedule a time for consultation directly
after the educational session or contact the DNP student via email to schedule an appointment.
The DNP student updated the blocks of time as they were filled. The days of the week and the
times were changed weekly to reflect the complexity of diverse clinician schedules and to offer
more availability to all participants. If these times did not work for the clinician, email was an
additional possibility for consultation. The open consultation resource ran from May 2017 until
September 2017. During this time, clinician use of the open consultations was documented on
run charts.
In September, the referral data from May to August 2017 were collected and compared to
baseline referral rates. In September, the DNP student followed up with the clinicians at their
monthly mandatory staff meetings for fifteen minutes to complete the same post-educational
questionnaire (time 2 versus time 3) and a resource follow-up questionnaire (see Appendix L)
that provided closed and open-ended questions to evaluate the resources. The post-educational
data was compared to the post-questionnaire given at the initial education session. This offered
data to support the utility of the live consultation and laminated resource. The outcomes were
positive and supported clinical behaviors based on EBP guidelines for recommendations of
annual training programs and will be suggested for use at other local clinics.
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Timeline
To ensure a successful and viable project that was realistic and manageable, a timeline
with all the necessary steps was created (Moran, Burson, & Conrad, 2014). The DNP student
modified the timeline to reflect the discussions with the faculty project mentor (see Appendix K).
The assessment and planning of the project started in August 2015 and continued to January
2017, and included literature review, obtaining MOUs, holding focus groups to refine the
objectives, developing the educational session with sustaining resources, and creating a viable
timeline for the project. In May 2017, five educational sessions were given at the three clinics
and data collection (a demographic sheet, information sheet, pre- and post-questionnaires)
started. In September 2017, the post questionnaire was repeated along with a resource use
questionnaire. Analysis of the data started in August 2017 and continued until spring of 2018.
Measures
To ensure that the surveys gathered dependable data, the author used valid and reliable
preexisting questionnaires that were modified to match the project outcomes. Several measures
were used to collect data for this project, including a demographic data questionnaire, pre-and
post-questionnaire (baseline, post-educational session, and two months after the educational
session), frequency of clinician-initiated referrals (baseline and two months after the educational
session), use of resources questionnaire and an open-ended questionnaire after the project was
completed.
The demographic data questionnaire was utilized to identify trends and patterns of
participants (see Appendix J). First, a demographic questionnaire, constructed by the project
leader, was used to document various participant characteristics, such as highest level of
education, years of experience, and gender. The informational characteristics were useful in
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recognizing if particular segments needed additional resources, noting trends related to
experience, age, gender, or education, and identifying future program modifications and
refinements that needed to be considered for certain demographics.
Second, a valid and reliable questionnaire adapted from the knowledge, attitude, and
practices (KAP) model developed in the 1950s (Launiala, 2009) and was modified to evaluate
baseline clinician knowledge, confidence, and beliefs before after the educational session, at
different intervals (before, directly after the educational session, and two months after the project
completion; see Appendix H). Referral rates from each clinic documenting referral rates at
baseline and two months after the educational session were measured to note any changes in the
clinicians’ patterns of referrals. Finally, a follow-up questionnaire regarding the use and
practicality of resources was given two months after the educational session (see Appendix I).
This open-ended questionnaire was included in the last data collection time point. The
questionnaire was developed by the author to determine if the resources were used and
advantageous to the clinicians after the educational session.
The project expenses used to measure the data were consistent with the anticipated
budget and were relatively low. Detailed data was listed in the statement of operation and 3-5year budget plan (see Appendices L and M). There were no unexpected costs to the project.
Analysis
Targeted objectives were evaluated, and the comparison of intended goals was
summarized. Outcomes one and two were related to the primary input of obtaining the
endorsement and engagement of clinic owners (see Appendix F for MOUs). The measures to
meet the project objectives were direct consultation with clinic owners, subsequent face-to-face
meetings with clinic owners, and attendance at participant monthly meetings before and after the
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project. The actions for this input included sending letters of participation and having two to five
program planning meetings at each clinic facility. Outcomes three through five were associated
with inputs targeted at the development of an educational program that sought to improve
clinicians’ psychopharmacology literacy. These outcomes also developed and implemented the
survey tools used in the project.
The statistical design used to analyze the demographic and pre-and post-questionnaires
was quantitative data analyses. Descriptive statistics were used to describe demographic
characteristics, such as highest level of education, age, gender, and years of experience, and
allowed the project leader to understand if possible relationships existed between these variables.
The demographic data, in outcome eight, was then analyzed by measuring means and standard
deviation statistics for age and educational experience. Findings supported outcomes nine and
ten. Providing clinicians education about psychopharmacology increased knowledge,
confidence, and beliefs by at least 10% directly following the session and by 15% two months
after the session, when combined with the educational resources.
The summation of outcomes nine and ten hypothesized improved clinician education
about psychopharmacology positively, which would influence knowledge, confidence, and
beliefs by at least 10% directly following the session and by 15% two months after the session,
when combined with the educational resources. Outcomes nine and ten were associated with
data collected from the two surveys (pre-and post-time 1 versus time 2, and time 2 versus time 3)
and were analyzed using counts, percentages, means and standard deviations and comparison of
t-scores (see Appendix N). Identification of trends and patterns among the data was considered.
The t-test analysis looked at the difference in percentages and any relationship between
variables.
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Clinic referral rates increased by 10%, and at least 20% of clinicians were projected to
access one of the resources after the session in outcomes eleven and twelve. This information
was reported in a table (see Appendix N). Outcome 11 was analyzed by obtaining retrospective
chart audits to record the number of referrals per month. Baseline referral rates were collected
for three months (March to May 2017) prior to the start of the project and during the project,
from June until August 2017. This was displayed in a run chart (see Appendix N). This type of
analysis was used to evaluate whether clinician referrals to medication management changed,
and to assess referral trends after the educational session and resources were made available.
Outcome 12, which was to have at least 20% of participants, by September 2017, access
one of the resources after the educational session, initially was going to be analyzed by using
counts, percentages, means, and a run chart; however, because of lack of participation, only a
count was performed. In addition, an open-ended questionnaire was given to participants to seek
further information regarding use of resources. The data were ranked categorically to determine
if there were any common requests or issues. This analysis offered insight about frequency of
use resources, applicability, utility of the resources and any necessary modifications needed to
make the resources more useful.
Ethical Considerations
Protecting the basic human rights of the program participants was paramount in the
project (Issel, 2014). Only clinicians were considered as participants in the project, but it was
understood that any person potentially affected needed to be considered and protected as well.
To protect the participants in the project, the project approval from the Boise State University
institutional review board (IRB) was prior to being initiated. There were no notable conflicts of
interests.
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Names or other identifying characteristics were not collected. Participation was
confidential and voluntary. The questionnaires were not shared with the clinic owners to
maintain confidence with participants and to prevent reprisal. The questionnaires were collected
in a secured lockbox placed at the front reception areas at each office and the DNP student had
the only key to the lock box. The boxes were not in patient accessible areas.
Controlling for bias in quantitative models improves reliability and confidently reports
that objective goals were met. In this project, selection bias and response bias were assessed.
The attempt to reduce selection bias was made by using clinicians from 3 different outpatient
clinics in two counties and from unrelated clinics. Also, employing a prospective design, rather
than retrospective, offered more rigorous criteria.
To protect against response bias, the evaluator issued a welcome letter that clearly stated
the confidentiality protection and the purpose of the project. Completed pre-and postquestionnaires were placed in return boxes that were secured in the front reception areas, which
this author did not frequent during the project. These methods were designed to strengthen the
confidence of the participants that all feedback would be confidential and that they could respond
without worrying about retribution or pleasing the evaluator.
Results
Referral rates steadily increased during the implementation phase, and, by September
2017, the outcome 11 goal was met. There was at least a 10% increase in the three clinics’
database for referrals for medication management, compared to referral rates before the
educational session. The baseline referral rate at clinic one was 10 referrals per month (March
2017-May 2017) compared to 11.6 referral calls per month during the implementation phase
(June 2017-August 2017), a 1.6% increase. Clinic two had 7.6 referrals from March to May, and
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8 referrals from June to August, representing a 1% change in quantity of referrals (see Appendix
N). Clinic three demonstrated the most significant difference in referrals before and after the
educational session, with 14.6 referrals during the baseline time period, followed by 21.3
referrals per month from June 2017 to August 2017, a 48% growth (outcome 11).
The tool had three subscales: knowledge, beliefs, and intentions (or attitudes). A t-test
was used to determine whether outcomes 9 and 10 showed differences in knowledge, beliefs, and
intentions before and after the educational session (see appendix N). In evaluation of the beliefs
data before the educational session (time one) compared to directly after the educational session
(time two), means did not show statistically significant differences. Two variable factors,
however, did have variations in time two versus time three. Clinicians who strongly agreed that
they should have a working knowledge of psychopharmacology to improve effectiveness and
who agreed there is a lack of clinician knowledge improved in time two versus time one, t (17) =
1.84, p = 0.04 (see Appendix N). The knowledge questions were related to the improved
comfort with psychopharmacology after the educational session. Eight out of the nine
knowledge data sections indicated significant differences between time one versus time two, and
half of these educational scores improved in time two versus time three (see Appendix N).
Intention values were all significantly changed after the educational session, represented in time
one versus time two (see Appendix N). The clinicians’ intent to use evidence-based practices
persisted in time two versus time three, t (17) = 2.91, p = 0.004).
All of the clinicians completed the demographic questionnaire (outcome 8). The
clinicians who participated in this project were majority female and had a minimum of a master’s
degree (see Appendix N).
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The open consult objective in outcome 12 was not met since none of the clinicians sought
an open consult by September 2017, which was a standard of participants who received training
using at least 20% of the resources evidenced by quantitative data from the resource follow-up
questionnaire. The data, however, obtained in the resource questionnaire, displayed a 27% use
of the paper and desktop resources. After the educational session, resource use was steady; six
times in May, five in June, seven in July and four times in August (see Appendix N). There was
no open-ended feedback to evaluate.
One contextual element that may have impacted the results is the size of the clinics. Two
of the three are relatively small in comparison to the last. More patients are seen and referred to
the largest clinic, because it is the most recognized in the general geographic area. Another
contextual element is the fact that the author has a longer relationship with the larger clinic,
which might have influenced participation and the use of resources. The last contextual element
is the turnover of clinicians at one of the clinics that saw the lowest change in referral quantity.
Two clinicians left this practice in the middle of the project, and they both were considered,
informally, as the most motivated clinicians.
One unanticipated issue was a complete lack of engagement and participation in the
offered live consult resource. None of the clinicians used this resource at any point in the
program. Frequent focus groups did not reveal obvious modifications that would improve use,
and, during these focus groups, clinicians suggested that they were motivated to use the live
consult, but this was not validated by the data. Further evaluation is required to determine what
modifications can be made to this resource to make it more immediately appealing to
participants. Another unintended issue was missing data from one pre-questionnaire. This
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changed the number of participants in time one versus time two to seventeen. This participant
did, however, complete the subsequent questionnaires.
From a budgetary standpoint, the project was relatively low-cost and there was no
external funding. The budget was covered by the DNP student and in-kind donations from the
organization. The highest cost was attributed to the DNP student’s consultation time. The
estimated expenses were consistent with the actual expenses. There were no unexpected costs.
Quarterly consultation was $750.00, which provided two hours of consultation at each clinic.
There were no consultation calls, but time was allotted and considered on the same basis as a
paid call. Printing materials, supplies, and equipment were $150.00 (see Appendix L).
Summary
This project explored the baseline knowledge, confidence, and beliefs of common
medications used in a mental health clinic setting, held by behavioral health clinicians. It also
looked at combined educational sessions and medication resources to influence and sustain
positive behaviors. Poor knowledge of psychopharmacology principles and rationale can affect
clinicians’ clinical decision responses and attitudinal biases, which can affect clinical behaviors.
Clinicians who have negative beliefs about psychopharmacology can inadvertently influence the
patients’ receptiveness towards referrals and medication compliance (Moses & Kirk, 2006),
resulting in poor patient compliance, untreated mental health illness, continued financial burden,
and poor resolution of the genuine issue (Bride et al., 2013). The project assessed the
relationship between clinician self-reported psychopharmacology knowledge, beliefs, and
confidence and differences in repeated self-reported questionnaires after an educational session
at two different intervals. In addition, the use of self-reported scores were evaluated in
conjunction with referral rates of clinicians and the use of the medication resources. It was
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anticipated that the information gained from this inquiry would help refine an educational
session and resources for sustainability.
Interpretation
Beliefs
Beliefs are problematic to transform once habituated (Kurz, Gardner, Verplanken, &
Abraham, 2015). This makes the task of altering beliefs challenging. The project leader
considered the difficulty in changing beliefs with one educational session. Although there was
not a statistically significant difference between the different time points in the beliefs
questionnaire, the mean score consistently improved over the three intervals. This may be
because clinicians’ beliefs were already favorable toward the use of medications before
education. For example, clinicians responded to the following three items as strongly agree to
agree: medication can improve effectiveness of mental health; patients can overcome mental
health illness; and basic medication literacy is their responsibility. During time two versus time
three, the belief that clinicians should have a working knowledge of medications and clinicians’
lack of knowledge scores were statistically significant. This may suggest that the information
gained further uncovered the absence of knowledge among clinicians, and with more they
learned during the educational session, the more they may have decided medication literacy was
a responsibility of clinicians. The results follow previous research that showed that clinicians do
feel a responsibility to improve their knowledge base about medications and viewed it as part of
their occupational role (Hughes & Cohen, 2010; Osborne et al., 2013).
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Knowledge
The knowledge section asked if clinicians understood mental health medications and
mental health symptoms. In addition, six commonly used classes of medication were assessed.
Every section of the knowledge questionnaire had consistently elevated means at all three
intervals, suggesting strongly that basic knowledge improved directly after the educational
session, and 80% of the scores improved from time two to time three, suggesting that education
was sustained over the last two months (see Appendix N). During time two versus time three the
most significant change was seen in the clinician’s ability to recognize that medical issues can
present as mental health issues and their understanding of mental health medications. This
indicates that in subsequent questionnaires, clinicians retain knowledge about the medications.
The project complemented studies that exposed clinicians’ inadequate training, education, and
comfort with psychopharmacology rationale and that enhancing knowledge improved basic skills
(Bentley et al., 2005; Casini et al., 2013; Hemingway et al., 2014; Shirazi et al., 2009).
Attitudes
Intention and confidence, as a variable, was measured based on self-reported scores (see
Appendix N). All confidence and intention scores improved compared from time one to time
two, but the most significant circumstance occurred when the clinicians felt prepared in
psychopharmacology. Time one scores, before the educational session, were consistently
reported in the “disagree” and “neutral” categories. Directly after the educational session (time
two), mean scores were steadily reported in the “agree” category. Lastly, in time three,
clinicians continued to rate more confidence in feeling prepared in psychopharmacology.
Overall, clinicians appeared to feel more confident, prepared to discuss and consult medications
with patients and providers, and had a clear resource, after the educational session. These results
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are consistent with previous studies that psychopharmacology education improved clinician
confidence and beliefs about medications (Mitz, 2005; Thompson et al., 2000).
Referrals
Referral rates increased steadily at two of the clinics and increased significantly at one
clinic. The trend of referral rates suggested improved referral for medication management after
the educational session. The consistent increase in referrals after educational sessions reiterated
the literature that clinicians with more experience and knowledge about medications had more
positive responses towards medications and the positive advantage of treatment predicted the
likelihood to perform new behaviors, such as referring for medication management when
appropriate (Moses & Kirk, 2006; Perkin, et. al., 2007). These referrals also reinforced previous
observations that clinicians can reduce the severity of missed opportunities in medication
adherence by reinforcing basic pharmacology principles to their patients and offering direct
guidance for referrals (Bee et al., 2008; Fortney et al., 2011; Gilles et. al., 2015; MartinezGonzalez et. al., 2014).
Resources
The lack of taking advantage of the open consult was unexpected, but the use of the
medication paper and desktop resource was substantial, indicating references given at the
educational session were useful after the initial session. Clinicians actively applying current
evidence in practice supported the applicability of the educational session and appropriateness in
practice. The results lend support to the concept that educational programs which reinforce basic
pharmacology principles in the workplace can improve clinicians’ knowledge, confidence, and
beliefs, which can ultimately generate improved patient outcomes (Bentley, Walsh, & Farmer,
2005; Bentley & Kogut, 2008; Breggin, 2016).
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Summary of Interpretation
The project confirmed previous studies and trials that examined improving clinicians’
knowledge, beliefs, and confidence about psychopharmacology through basic educational
sessions, thus changing negative beliefs about medications, improving confidence, and
predicting appropriate referrals for medication management (Baik et al., 2008; Bride et al., 2013;
Burgermeister et al., 2012; Hemingway, Rogers, & Elsom, 2013; Liu et al., 2008, Casini et al.,
2013). The project noted the greatest benefit for all self-reported categories directly after the
educational session. The beliefs and confidence scores did not differ much from time two to
three. Knowledge scores, however, did show consistent improvement over two months, which
may direct project refinement to focus on beliefs and confidence for future sessions. The most
significant change in self-reported scores was in clinician confidence, in which they “felt well
prepared in psychopharmacology.” Time one represented scores associated with “neutral”
agreement, time two and three scores associated more closely with “agree” (see Appendix N).
The results of these questionnaires met outcomes nine and ten, which were related to selfreported scores improving at least 10% in time one versus time two and time two versus time
three.
Previous studies have illustrated that clinicians’ knowledge and confidence with
psychotropic medicines was predictive of appropriate referral for medical management, and the
increased likelihood that clinicians would recognize appropriate referrals and improve
coordination with providers (Bentley et al., 2005; Stern et al., 1999). Referral rates were gradual
after the educational session. Referral rates also met project outcomes eleven in two clinics, but
one clinic had an unexpectedly highest average after the educational session. One assumption
for the differences in rates from the other clinics is that the high average clinic was the largest,
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most recognized in the area, and the busiest. Another development is that the clinic lost two
clinicians in April, then subsequently hired three additional therapists who came with an existing
patient load. This patient load may have been considered “new medication referrals” because the
clinic did not separate the data. Those incoming clinicians were offered the educational session
too, so it is unclear exactly why the rates were elevated in comparison to the other clinics. In
future projects, the goal will be to examine clinics by controlling for significant turnover as a
new variable.
Although use of the live consult resource was poor, the use of the laminated and desktop
resources met objectives in outcome twelve. The laminated and desktop resources were accessed
about six times a month. The sole use of the laminated and desktop references (combined with
an educational session) may support that clinicians felt those resources were sufficient enough to
guide them and did not require more intensive live consultation.
Policy Implications
The project was not actively pursued for policy or political development in this primary
stage. Although this project was not directly political, it does validate future political and policy
implication analyses related to mental health care coverage, access, and funding. Under the new
health care proposal, there will be continued reductions to health care coverage and access. The
insurance gap will widen due to restructured income qualifications, reduced tax subsidies,
deregulation of health care payers, removing mental health care as an essential benefit, and
escalating premiums (Closing the gap, n.d.). As a result of these significant changes, millions
will be displaced from being insured (Busch, 2012).
The next step for policymakers is to ensure that access to mental health care is available,
affordable (both to the organization and individual), that quality health care is reimbursed, and
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that the divide is reduced between who can and cannot afford health insurance. There are many
policy and political movements occurring in both national parties to improve health coverage,
but there remains a sharp divide and lack of consensus on what will shape the new standards
(Barry, Huskamp, & Goldman, 2010). The recommendations from a mental health care
perspective are to ensure policy is implemented with best practice, high-quality integrated
evidence. This evidence should be made available by federal and state agencies for providers via
tool-kits, algorithms and online resources. Mental health illness is variable, and response is
diverse; therefore, it requires policymakers to acknowledge individuality in prescribing. This
means access to an open formulary for customized treatment. Prescribing should not be guided
by the available formulary, but, instead, policymakers should support policies that ensure that
safety, tolerability, clinical appropriateness, and affordable costs are the main guides to treatment
choices. Additionally, policymakers need to address controlling the costs of medications from
pharmaceutical companies so that limitations are not based purely on costs but clinical
significance, appropriateness, utility, patient response and provider judgement (Parks, Radke, &
Tandon, 2008).
Limitations
Several study limitations necessitate mention. Foremost, the sample size, 18, was small
and may have impacted results. The student actively reminded clinicians, at least weekly, of the
ongoing program in an effort to encourage more participation. During the interpretation phase of
the project, attendance at staff meetings was consistent, to preserve open dialog about the
resistance to the use of consultation. Feedback consistently found that it may have been
unnecessary. Perhaps, future efforts could include obtaining more participants in different types
of clinics in both urban and rural areas.
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Another limitation was selection bias, which occurred in the data collection because
participants were not adequately randomized. This can prevent generalizability to the larger
population. The attempt to reduce selection bias was by means of using clinicians from three
different outpatient clinics in two counties and from unrelated clinics. For future comparisons,
using clinicians from multiple clinics and counties would be desirable, as a way to further reduce
selection bias and improve generalizability.
Additionally, relying on self-reported data limits the ability to independently verify the
information. Self-reported material can contain other biases, such as attribution and
exaggeration. Lastly, there were no calls for individual consult. A low number of participants
reported using the laminated resource, yet questionnaire scores continued to increase from time 1
versus 2 and 2 versus 3. This may suggest that perhaps the educational session was sufficient,
and that clinicians did not feel like they needed to use any additional resources. However, the
resources will need to be evaluated for practice applicability and modified in order to make it
meaningful to clinicians.
Conclusion
The objective of this project was to generate new clinician knowledge and confidence
that supports patients who are prescribed medications, while also improving new referral rates
for medication management, by presenting an educational session that influenced positive
clinical behaviors, based on previous research evidence (Thompson-Leduc et. al., 2014). The
project met the majority of the outcomes and did support previous findings in the literature. This
project was well-received and embraced by the clinic owners and clinicians, highlighting the
need for continued education services. The usefulness of these findings in practice can be
beneficial to the clinicians, clinic owners, prescribers and, eventually, patients. For clinicians,
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the improved knowledge will promote confidence, align beliefs with current available evidence,
and enhance the referral process. For clinic owners, it provides astutely-trained clinicians, and
collaboration and cohesion between medication management and therapy, which is superior for
patient mental health outcomes.
To encourage sustainability, the evaluator will recommend that each clinic conduct
continuing annual education services and provide a resource tool for common
psychopharmacology medications for use after the educational sessions. These services will be
offered through arrangement of being compensated based on the evaluator’s current hourly rate.
The next step would include refining the resources, making them more valuable to the
clinicians, and then advertising services to the pilot clinics for reimbursed implementation.
Long-term objectives would include having the clinics establish a new model of care built on
evidence reinforced by this pilot project, improving collaborative relationships with prescribers,
and improving clinical outcomes of the patients receiving medications.
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Table A1
Synthesis of the Evidence
Article Author
#

1

& Date
Baik

RCT

Limitations

the EBP question

et al.,

Describes the significance that clinical
experience plays in recognition and
management of depression

8
providers

2008

Small sample, limited

& Quality

2B

longitudinal
data, specific setting

□
2

Level

Study findings that help answer

Evidence Sample, Sample Size
Type
& Setting

N/A
Inclusion of mental health literacy

Not a RCT, narrative review, 3B

tive

In nursing practice curriculum can

non-experimental

review

improve provider confidence

Burger-

Narra-

meister,
Kwasky,

N/A

& Groh,
2012

3

Casini

Quasi

816

Teaching basic skills for recognition

Generalizability is limited,

et al.,

RCT

primary

and management for depression

unexpected finding of poor

care providers

can improve provider confidence

confidence, may need

and comfort

qualitative study to answer

2013

questions, education needs to
be tailored to experience

2A
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□

In order to evaluate the utility of

Specific population, not

James, &

Clinical
practice
guide-

clinical guidelines in practice and

generalized, homogeneity

Cowan,

lines

provider adherence it must be measurable to
extrapolate

Graham,
4

N/A

2000

4B

meaningful information

□
Hemingway,RCT
Rogers, &
Elsom,
5

2013

67 APN

N/A
Mental health literacy and APN

students

students’ confidence can improve
with specific education in the
curriculum

Small sample size, results not 1B
followed, student bias, no link
in interventions and patient
outcome

N/A
Liu, Lu & RCT
6

Lee, 2008

375 non-physicianPoor confidence, knowledge of depression Geographically
and
located may be2A
it suggest that beliefs and attitudes are
providers
difficult to generalize, more
influenced by this
male providers, already
received depression training, bias,
weak correlation

EDUCATIONAL SESSION

46

□

7

O'connor,

Syste-

2009

matic

33 articles
synthesized

Screening and recognition of

Targeted area of concentration,1B

depression is unlikely to influence outcomes
poor generalizability, short
without additional
follow up, high placebo rates,
support
small sample size

review
with

□

meta

N/A

N/A

analysis
Naji et al., Quali-

442

Practice nurses do not feel

Low response rate, clinical

2004

practice

prepared to work with depressed

behavior not well established

nurses

patients

tative

8

□
Shirazi

9

RCT

192

et al.,

general

2009

practitioners

N/A
Provider behavior towards

3A

Control arm received 8 hours 1A

Management of depression can be influenced
Of training while the
positively by tailoring education to each
Interventional arm received
provider
12 hours, high
attrition, small sample size
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□
Siu, 2016
10

Clinical
practice
guide-

N/A

Thompson, et
RCT
al., 2000

Does not discuss ways to

4A

standard EBP recommendations for screening
improve practical use in
of depression
practice

lines

11

N/A
Reinforcement of current gold-

232 prac-

Outcomes of depression in patients did

Depressives were studied but 1A

tices with

not improve however, it did

not depression as a diagnosis,

4192

highlight improved provider

ceiling effect, trial design

patients

confidence and education was well received

with
depression

Vicente
12

et al.,
2007

RCT

Improving provider training and competencies
Limited longitudinal data,
can improve
2598 pts evaluated
varying demographics, 11
management of depression
month follow up, low
37 MDs,

1A
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□

13

Springer & RCT
Harris,
2010

322

N/A

Over 80% of the therapist felt Self-reported
1B!A1
information,

marriage andinadequately trained in
family
psychotropic medications,
therapist,
outpatient
therapy
setting

inflated responses, no scales

to measure therapist attitudes
therapist with a
psychopharmacology class in on medications, generalizabilitytheir curriculum identified a
medication referral earlier

Anglo, marriage/family
therapist, internet data
collection, response rate

14

Rice et al., RCT

180

Negative attitudes toward

Small sample size, testing

2010

therapist

EBP, lack of knowledge and

was modified to fit therapist

1B

from Social skills for using EBP
Workers
Association then
randomly
Divided
into 2
groups
15

Feros et

Non-ex-

al., 2010

perimental clinicians

medication in general and in

study,

effectiveness in depression,
providers with prior

descripttive

72 health

Ambivalent attitudes towards Small sample size, specific

medication training had more
positive attitudes with
medications
and felt more that it was part
of their role to facilitate
adherence

sample size, not a RCT

3A
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Bride et
al., 2013

49

Non1227
Therapist with higher degree Self-reported data, response
experimencounselors, Levels had more positive
bias, limited ability to
tal study
attitudes towards EBP practice determine
and
social
causality, specific
support use of medications in
workers
setting
SUD treatment
and

3A

therapist

17

Moses &

Cross-

260 social
workers

Social workers and therapist

Self-reported response,

3A

with more experience and
Kirk, 2006 sectional
response bias, poor diversity
and therapist knowledge with medications
survey
of respondents, poor
from
had more positive responses,
response rate
national
social workers and therapist
social
may benefit from
worker
psychopharmacology
association
education from medical
professionals
18

Hughes &
Cohen,

19

Systematic175 RCTs
Review

Social workers have a role in Not a RCT, inconsistent
further understanding

assessment models,

2010

patients’ drug effects

heterogeneity

Dziegielewski
Quasi&
169 social
Leon, 1998 experimental
workers

Social workers equipped with Not randomized, specific

3A

2A

basic knowledge of commonly sample
and therapist used drugs allows social workers
to
actively participate in the
interdisciplinary team and
provide information to
providers about patient
response and adherence

20

Cohen,
2002

Systematic368 studies Social workers and therapist Not a RCT, specific sample
review
can look at clinical studies and
without
research through EBP
Meta

methods and improve

analysis

their personal knowledge
which can influence other

1B
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social workers and therapist

21

Stern et
al., 1999

22

Byrne

74 physicians,Attitudes of health care
Non-experinonprofessionals can influence
mental
physicians, patients’ access to
study
psychodepression treatment
therapist

Small sample, old study,

Quasi

et al., 2004 experimental
study

poor generalizability given
new standards of care and
development of newer
antidepressants

23 mental

Basic medication and

Sustainability, did not

health

medication

measure response in actual

care workers adherence educational
opportunities improved the
knowledge of mental

2B

2B

clinical practice, interrater
reliability, not randomized

health care workers
23

Ng et
al., 2012

24

Non119 mental Patients’ attitudes and beliefs Heterogeneity, self-reported,
experimental
health
towards medications should
cross-sectional, selection
study
patients
be assessed by all mental
bias, not a RCT
with
health clinicians because
affective

attitudes and beliefs can

and

influence medication

psychotic
disorders

adherence

Integration of a specific
psychopharmacology course

Mintz,

Expert

Medical

2005

profess-

residents

Not a RCT, level 4 evidence,

ional

specific setting
during residency improves skills
during their and

opinion

residency

3A

4B

confidence

Systematic52 RCTs, Evidence-based education and Not a RCT, specific setting,
review
Walsh, &
noninformation given to social external validity
Rosemary, of RCTs,
experimentalworkers can improve EBP
non2005
studies,
referrals
experimental
descriptive
studies,
qualitative studies
studies

3B

Systematic26 selfreview
McRee, &
reported
of RCTs,
Kasseguidelines,test to
nonbaum,
screen for
experimental
studies of self-

2A

25

Bentley,

26

Babor,

These screening test are brief Not a RCT, specific setting,
and manageable to add to a

specific population, external

social worker’s patient

validity

evaluation and could lead to
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reported drug and
testing
alcohol
test

51
EBP referrals for medication
management of drug and
alcohol
recovery

27

Farinde,
2014

SystematicCould not
review
determine
without

Improved collaboration with

No meta-analysis, not a RCT,

pharmacist and therapist can
improve timely referrals,

small sample, specific setting

meta

increase patient consultation

analysis

with pharmacist about

3A

and population, external
validity

psychotropic medications and the
opportunity to improve
patient outcome

28

Haddad

RCT

Gunn

Quasi

et al., 2010 experi-

workers’ attitudes towards
depression

election bias, external

5 private

Shared understanding of

owned

conceptual frameworks are
recommended to

Limited involvement in the
organization's policies or

mental

clinics and

study

1
community
health care
center

30

Thota
et al., 2012

The revised scale is reliable forConvenience sample,

1A

healthcare evaluating training that looks specific setting, limited
professionals
at therapist and social
applicability, response rate, s

et al., 2015

29

1213

Systematic69 RCTs
review
With
meta
analysis

improve collaborative care

validity, missing data
2A

procedures, input of data
inconsistent, limited staff
commitment, immense data

among healthcare providers

Collaborative care models are Selection bias, differential
effective at improving

effects by severity of

networking,

depression, attrition bias,

support and public health

referral bias, only use of RCTs

outcomes

1A
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Rush &
Trivedi,

NonN/A
experimental
study

2009

52
Measurement tools can help Self-reported, not a RCT,
establish a diagnosis, measure
specific setting and
symptomatic outcomes and
population, external validity
adverse effects. Can

3A

provide more clinical
information
33

Osborne

Non-

et al., 2013 experimental
study

N/A

HLQ supports validity in
intervention evaluation and
surveys of the
capabilities of individuals.
May use as a tool to measure
therapist health literacy

Low response rates, specific
setting, lower reliability,
absence of data

1B
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Appendix B

Figure B1. Theoretical framework (Thompson-Leduc et al., 2014).
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Appendix C

Table C1
Project Framework Iowa Model

Note. Adapted from "Nurse Practitioner Care Model: Meeting the Health Care Challenges with A
Collaborative Team" by J. Kutzleb, R. Rigolosi, A. Fruhschien, M. Reilly, A. M. Shaftic, D. Duran, and D.
Flynn, 2015, Nursing Economics, 33, no. 6 (2015): 297.
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Table D1
Logic Model
Resources/Input

Activities

Outputs

Outcome
Short
term

Outcomes:
Long term

Impact

Includes the
human, financial,
organizational, and
community
resources a
program has
available to direct
toward the work.

Includes the
processes, tools,
events,
technology, and
actions that are
intended to bring
changes or results.

Direct products
of program
activities and
may include
types, levels and
targets of
services to be
delivered by the
program.

Specific
changes in
program.
SMART.

Specific changes
in program.
SMART.

Fundamental
intended or
unintended
change occurring
as a result of
program activities
in 7-10 years.

Endorsement
and engagement
of 3 clinic
owners

Write a proposal
to present to
clinic owners
for an
educational
program that
will improve
clinicians’
knowledge
about
psychotropic
medication
management
and rationale for
referral

At least 1 faceto-face
meeting with
clinic owners
to initiate
program and at
least 1 email
about proposal

1. By

13. By 2020,

August
2016,
quarterly
consultatio
n with
50% of
clinic
owners
regarding
the
developme
nt and
delivery of
the
educationa
l program
will occur

the educational
program is
conducted at
all 25% of the
clinic sites
annually

Majority
participation of
local outpatient
mental health
clinics in the
educational
program

Develop and
strengthen
relationship with
clinic owners
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Face-to-face or
phone call
once a month
to update
progress or
discuss issues

Attend staff
meetings
monthly before
and after
educational
program is
piloted
Behavioral
Health
Clinicians

Conduct
program
development
groups to
determine
priority, gaps
and needs of
psychotropic
medication
literacy

Develop
participation and
welcome letter
about purpose of
the project,
contact
information and
goals

Develop
program
development
groups of 2-5
clinicians at
each clinic

Develop and
write the
welcome
letters to 100%
of participants
and clinic
owners,
estimate about
20
participants.

2. By
Sept.
2016,
will have
at least 1
program
planning
meeting
at one of
the
mental
health
clinic
facilities

14. Quarterly
consultation
with 60% of
clinical owners
regarding the
development
and delivery of
the educational
program,
starting March
2019

The
psychopharmac
ology
educational
session will
become standard
practice for
clinicians

15. By March

Clinicians can
develop own
program
planning groups
to modify the
educational
program content
to match their
needs

2019,
clinicians have
improved
knowledge.
confidence.
and beliefs by
10% in the first
post
questionnaire
(time 1)

16. By March
2019, there
will be a 20%
increase in
referrals for
medication
management at
all 3 clinics

Participants are
confident about
using the letter
to broach other
clinicians to
attend an annual
psychopharmac
ology
educational
session
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(May consider
sending via
email to
reduce cost)

Development of
educational
program to
improve
clinicians’
psychopharmac
ology literacy

Identify
demographic
tools

Identify,
research tools to
measure
knowledge,
beliefs,
confidence to
measure
response to the
psychopharmac
ology
educational
session

Develop an EBP
educational
program about
psychopharmac
ology

Research
preexisting
demographic
questionnaires
for background
information to
identify trends
and patterns

Implementation
of a knowledge,
confidence and
beliefs
questionnaire to
evaluate
efficacy of the
psychopharmac
ology
educational
session

Analyze and
synthesize
results
knowledge,
confidence and
beliefs
questionnaire
and
disseminate to
faculty advisor

3. By
August
2016, a
demographi
c tool,
knowledge,
confidence
and beliefs
questionnai
re, and
follow-up
resource
questionnai
re is chosen
and ready
for
implementa
tion by May

2017

4. By Sept.
2017, 50%
of the
participants
in the three
clinics
complete
the second
post
knowledge,
confidence
and beliefs
questionnai
re and
resource
follow up
questionnai
re

17. By March
2019, the
educational
program is
offered to 2
other local
clinics in the
Boise area

The
demographic
tool will be
standardized and
used by other
local clinics
before initiating
training for the
psychopharmac
ology
educational
session

18. By March
2019, of
participants
who receive
training, 30%
use the
resources
evidenced by
quantitative
data from the
resource
follow-up
questionnaire
The tools will be
recognized as
standard
applications in
national mental
health clinics in
conjunction with
offering a
psychopharmac
ology
educational
session
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educational
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Development of
a resource for
participants to
use after
training (webbased
application,
algorithm or
pocket guide)
and provide
training to use
them
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Develop
estimated
45min
educational
intervention to
participants at
mandatory
monthly
meetings

The knowledge,
attitude and
beliefs
questionnaire
will be
recognized as
standard in all
national mental
health clinicians

5. 80% of
Educate
participants
about how to
use the
resource
materials and
distribute to
each clinician
after the
educational
program

all
participants
trained on
the use of
the resource
and has a
copy or
access to
the resource
by June
2017

Become a
consultant for
training other
practitioners to
provide the
training to
clinicians in
other states and
clinics

Improved selfreported patient
quality of life,
reduced
disability

Decreased
financial global
burden

Nationally
recognized
resource for
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other mental
health clinics

Implementation
of a
psychopharmacol
ogy educational
session

Training and
guidance to
clinicians about
the
psychopharmac
ology
educational
session

A 45-min
educational
training
program will
be given at the
3 clinics to
75% of
participants
once every
week from
May 2017
until
November
2017

Evaluate
responses and
feedback
weekly, from
implementation
May 2017 to
November 2017

6. By July
2017, 50%
of
participants
in all three
clinics
complete
the initial
pre-and
postknowledge,
confidence
and beliefs
questionnai
re

7. By Sept.
2017, 50%
of
participants
in the three
clinics
complete
the second
post
knowledge,
confidence
and beliefs
questionnai
re

19. By March
2019, at least 1
clinic applies
the
psychopharmac
ology
educational
session through
a policy change

20. By March
2019, a 20%
increase in the
clinics’ data
base for
referrals for
medication
management in
all 3 clinics

Improved
provider and
clinician
collaboration

Improvement in
undergraduate
and graduate
universities
adding and/or
emphasizing the
psychopharmac
ology in
clinicians’
curriculum

Improved
patient
adherence to
medications

Appropriate and
prompt referrals
for medication
management

Analyze and
synthesize the
results by
November
2017

Evaluation of
educational
program

Give
participants the
demographic
and knowledge,

Analyze and
synthesize
survey tools

8. By July
2017, 60% of
clinicians
complete the
demographic
questionnaire
and baseline

21. In 1-2 years
clinicians report
a 30%
improvement of
post
questionnaire

Standard use of
evaluation
practices in
other clinics
nationally

EDUCATIONAL SESSION

60
knowledge
questionnaire
(time 1)

confidence and
beliefs surveys

Evaluate
Post-training
goals

Meet with
faculty advisor
to discuss
program goals
and future
progress

Disseminate
results to
faculty and
cohorts

9. By July
2017,
clinicians
scores on
knowledge
questionnaire
(time 2) will
increase by
10% from
baseline
(time 1)

10. By
September
2017,
clinicians
scores on
knowledge
questionnaire
(time 3) will
increase by
15%
compared to
the baseline
questionnaire
(time 1).

11. By
September
2017, there
will be 10%
increase in
the 3clinic’s
database for
referrals for
medication
managemen
t compared
to referral
rates before
the
educational
session.

knowledge
scores

22. Continued
correspondence
with BSU faculty
1 year after the
program pilot for
guidance and
support of
continued
program efforts

Nationally
recognized
improvements
of attitudinal
responses and
knowledge to
psychotropic
medications
after using the
educational
program

Long-term
collaborative
relationship with
BSU faculty
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12. By
September
2017, of the
20
participants
who
received
training,
20% use the
resources
evidenced
by
quantitative
data from
the resource
follow-up
questionnai
re by Sept.
2017.
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Table E1
Outcome Evaluation Plan
Outcome

8) By July 2017, 60%

of clinicians complete
the demographic
questionnaire and
baseline knowledge
questionnaire (time
1).

9) By July 2017,

clinicians scores on
knowledge
questionnaire (time 2)
will increase by 10%
from baseline (time 1).

10) By September 2017,
clinicians scores on

Outcome
Instrument Data

Analysis Goal

Analytic Technique

Demographic
survey
questionnaire:
age, educational
level, experience

To determine if
the population is
representative of
the general
population,
observation of
trends.

Descriptive statistics look at variable data such as
highest level of education, age, gender years of
experience and allows the student to understand if
possible relationships exist between variables. I will
use statistical analysis for discrete data; measure
frequency statistics, percentage statistics for age,
educational experience, etc. and also use measures
of central tendency for continuous data. Evaluating
the frequency of data can improve interpretation by
determining the frequency and then figuring out the
percentage of that particular data.

Pre/post
education
questionnaire.
The
questionnaire is
adapted from the
knowledge,
attitude and
practices (KAP)
model, which has
been widely used
in previous
studies and has
established
reliability and
validity
(Launiala, 2009).

Descriptive
statistics using
counts,
percentages,
means and
standard
deviations from
the preeducational
questionnaire.
Establish
baseline data of
attitudes, beliefs
and knowledge
perceptions of
participants’
rankings before
implementation
of the
educational, will
be used in
statistical
analysis to see if
improvements
were noted after
the educational
sessions

Likert style questions may offer open-ended
questions that will require quantitative and
qualitative approaches to evaluate the results. The
closed-ended questions will have Likert scales that
are ordinal, will look at the difference in
percentages using a t-test, which looks at the
relationship between variables. For this project
examining the difference in scores after the
educational session will be examined more closely
with the statistical analysis

Retrospective
chart audit that

Provide strength
that the

Will use interval data from the organization’s
medical record to evaluate if per clinician referrals
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knowledge questionnaire
(time 3) will increase by
15% compared to the
baseline questionnaire
(time 1).

looks at number
of referrals per
month from
internal and
external sources

educational
intervention
optimized
referrals for
medication
management

to medication management changed. This can
better assess trends after the educational
intervention. A run chart could be used to compare
data about the trend of referrals. The run chart
would be from before the educational session was
given then 2 months after.

11) By September

Pre/post
education
questionnaire.
The
questionnaire is
adapted from the
knowledge,
attitude and
practices (KAP)
model, which has
been widely used
in previous
studies and has
established
reliability and
validity
(Launiala, 2009).

Describe and
summarize data
between pre/post
educational
intervention
scores, measure
of variability to
assess which
scores differ
around the
average, note
themes between
attitudinal
response, did
these improve
after the
intervention.
The surveys will
help note changes
in therapists’
referral
intentions,
changes in
patterns of
response to
patient and
medication, selfreported
attitudes and
behaviors.
Measure
perception of
knowledge, skill
building,
attitudes and
intent to change
practice. Gives
me more insight
about the
educational
intervention and
its effectiveness

Quantitative methods will be used to evaluate the
survey. Therapists will participate in one
educational session. The questionnaires will be
given to each therapist at their respective clinics
before and after each educational session. Plan to
use the paired T-test to compare the means of the
pre/post surveys. In the surveys obtained from
participants I will interpret any difference in the
mean of therapists’ attitudinal responses before and
after the educational session. The t-test would
evaluate the demographic survey by identifying the
means of experience, age, years of school, which
would be helpful to identify commonality. Will
measure for variability to assess which scores differ
around the average of scores. Inferential statistics
will be used to review the means with the use of SD.
Will calculate the mean and the SD separate in the
pre/post surveys then compare. Determining the
mean will help me summarize the variables across
all the participants and how much each varies from
the mean. Making inferences based on these
statistics can improve my ability to infer that the
results of using my educational intervention could
be generalized to the other populations. Will use Ttest and P-values to evaluate probability that
inferences can be made. T test is appropriate for
small sample sizes; my project will be around 20.
My sample is not a random sample (it’s a
convenience sample).

2017, there will be
10% increase in the 3clinic’s database for
referrals for
medication
management compared
to referral rates before
the educational
session.
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12) By September 2017,
of the 20 participants
who received training,
20% use the resources
evidenced by quantitative
data from the resource
follow-up questionnaire
by Sept. 2017.

Pre/post
education
questionnaire
(same as
above)

64

Observation
of trends using
descriptive
statistics. Use
counts,
percentages,

Analysis of the resource follow-up with a
run chart. Necessary to give insight about
frequency of use, applicability, utility of the
resources, modifications of resources

means

Launiala, A. (2009). How much can a
KAP survey tell us about people's
knowledge, attitudes and practices? Some
observations from medical anthropology
research on malaria in pregnancy in
Malawi. Anthropology Matters, 11(1).
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Appendix F

*MOU available on request

Appendix G
Welcome Statement
Cover Letter and Introduction
Educational Session to Improve Behavioral Health Clinicians’ Knowledge,
Confidence, and Beliefs About Medications
The purpose of this project to investigate whether an educational program about basic
psychopharmacology improves behavioral health clinicians’ knowledge, confidence, beliefs, and intention
to refer when appropriate. The project evaluator, who is a Boise State doctoral nursing student, will
present an educational session about psychopharmacology and then two short questionnaires will be given
directly after. Two months later, two follow-up questionnaires will be given. All feedback will be
confidential and voluntary; no identifying characteristics will be used. Please return responses promptly
in the designated box at the front desk.
As discussed at the end of the educational session, here is the email address to schedule consultation for
medication management questions: Sharcost5@icloud.com. If you have any questions or concerns about
this program, please contact Sharon Bennett at 208-863-6151 or sharoncostner@u.boisestate.edu. Further
questions can be directed to the principal investigator, Dr. Cara Gallegos at (208) 426-2643 or
caragallegos@boisestate.edu.
You may obtain a copy of the results at the Boise State University library after the project has been
completed, in June of 2018. Thank you for participating in this project.

EDUCATIONAL SESSION

66

Appendix H
IRB Approval

IRB approval
March 10, 2017
To: Cara Gallegos cc:
Sharon Bennett
From:
Office of Research Compliance (ORC)
SB-IRB Notification of Exemption - 187-SB17-045 Development and Implementation of an EvidenceBased Educational Session to Improve Behavioral Health Clinicians’ Knowledge, Confidence and Beliefs
About Psychopharmacology
The Boise State University ORC has reviewed your protocol application and has determined that your
research is exempt from further IRB review and supervision under 45 CFR 46.101(b).
Protocol Number: 187-SB17-045
Approved: 3/10/2017
Application Received: 2/28/2017 Review: Exempt Category: 2
This exemption covers any research and data collected under your protocol as of the date of approval
indicated above, unless terminated in writing by you, the Principal Investigator, or the Boise State
University IRB. All amendments or changes (including personnel changes) to your approved protocol
must be brought to the attention of the Office of Research Compliance for review and approval before
they occur, as these modifications may change your exempt status. Complete and submit a Modification
Form indicating any changes to your project.
Annual renewals are not required for exempt protocols. When the research project is completed, please
notify our office by submitting a Final Report. The exempt status expires when the research project is
completed (closed) or when the review category changes as described above.
All forms are available on the ORC website at http://goo.gl/D2FYTV
Please direct any questions or concerns to ORC at 426-5401 or humansubjects@boisestate.edu.
Thank you and good luck with your research.
Office of Research Compliance
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Pre/post Questionnaire

Pre/post Questionnaire
Educational Session to Improve Behavioral Health Clinicians’ Knowledge,
Confidence, and Beliefs About Medications
Statement

Beliefs
I believe clinicians should have a
working knowledge of
psychopharmacology to improve
effective treatment planning
I believe a working knowledge of
psychopharmacology can increase
therapeutic effectiveness
I believe medications can be an effective
way to treat mental health disorders
I believe clinicians have a lack of
knowledge of medications used in the
treatment of mental health disorders
I believe that patients can overcome
mental illness without the use of
medications
I believe basic psychopharmacology
literacy is part of my responsibility

Knowledge
I have an understanding of the
medications most commonly used to treat
mental disorders and know that mental
health symptoms can be mimicked by
other medical causes
I have an understanding of symptoms
caused by mental disorder medications
I understand the medications my patients
are taking
I have the knowledge of medications that
are used to treat sleep

Strongly
Agree

Agree

Neutral

Disagree

Strongly
Disagree

EDUCATIONAL SESSION
I have the knowledge of medications that
are used to treat anxiety
I have the knowledge of medications that
are used to treat depression
I have the knowledge of medications that
are used to treat bipolar disorder
I have the knowledge of medications that
are used to treat
schizophrenia/schizoaffective disorder
I have the knowledge of medications that
are used to treat ADHD

Intentions/Confidence
I use evidence-based referral practices
I have confidence in discussing basic
medication management with my patients
I feel confident reinforcing medication
management recommendations
I feel comfortable consulting with
medication management providers if I
have questions about medications
I have a resource for
psychopharmacology questions
I feel well prepared in
psychopharmacology
I have the skills to discuss basic
psychopharmacology with patients
I know whom to contact with questions

Additional Comments:
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Appendix I
Resource Follow-Up Questionnaire

Resource Follow-Up Questionnaire
Instructions
Please read each question and circle the response that best represents your answer or fill in the blank with your
answer.
1
)

How many times did you access the laminated resource?

a
.

none

b
.

1-3 times

c
.

More than 3 times

2
)

How many times did you access the live resource consultation?

a
.

none

b
.

1-3 times

c
.

More than 3 times

3
)

Was the laminated resource helpful? If no, why?

a
.

yes

b
.

no

________________________________________________

EDUCATIONAL SESSION

4
)

Was the live consultation resource helpful? If no, why?

a
.

yes

b
.

no
___________________________________________________
Were the live resource times convenient for you? If no, what hours would better

5
)

accommodate your schedule?
a
.

yes

b
.

No
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Appendix J
Demographic Questionnaire

Demographic Questions
Instructions
Please read each question and circle the response that best represents your answer or fill in the blank with
your answer.

1)

How many years have you been working in the mental health field?

2)

_____________What is your highest level of education?

a.

Bachelor’s
degree

b.

Master’ degree

c.

Other__________________

3)

In what discipline is your undergraduate major?
a.

Social Work

b.

Counseling

c.

Psychology

d.

Other________________
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Appendix K
Table K1
Timeline
Project: Educational Session to Improve Behavioral Health Clinicians’ Knowledge,

Confidence, and Beliefs About Medications
Activity

8/15

1/
16

5/16

8/16

1/17

5/

8/

17

17

Literature Review, mission, vision, problem
statement, timeline for project
Timeline

Project Goals and Objectives

Gain approval by IRB

Develop education modules, research survey
tools.
Make contact with providers
Develop educational session, resources
Educate and train therapist
Get returned feedback from therapist, synthesize
results
Disseminate results to clinic owners and
therapist
Final report
Obtain memorandum of agreement
Focus groups
Implementation of educational session
Implementation of 2-month post-questionnaire

X
X

1/18

98

EDUCATIONAL SESSION
Appendix L
Statement of Operations
Statement of Operations

Revenues

Facility Expense

450

Room expense, utilities at the 3 clinics to present educational sessions, 3 hours
per facility at $50 for each hour (estimated by clinic owners, in-kind donation
from clinics)

Grants (none applied for in year 1; anticipate applying in year 2)

0

Evaluation and Assessment

2475

Costs for student’s time (in-kind) for preparation of evaluation, analyses of
surveys, administration time to process results for dissemination, $75/hr. for 11
hours at 3 clinics
Educational Initial Training

2250

Salaries for the student (in-kind donated hours), $75/hr. for 10 hours per clinic
This is for the student’s contracted rate
Salaries for therapists (in-kind donation from clinics), $28/hr. for 20 therapists
for 1 hour

560

Total $5,735
Expenses

Administrative Supplies

150

Printer cartridges, printer, paper, copying, pens, phone services
Educational material, laminated resources, training material, surveys

Evaluation and Assessment

2475
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Costs for student’s time (in-kind student donation) for preparation of evaluation,
analyses of surveys, administration time to process results for dissemination,
$75/hr. for 11 hours at 3 clinics
Travel Expenses

60

Costs to travel to and from offices
Educational Initial Training

2250

Salaries for the student (in-kind student donated hours), $75/hr. for 10 hours per
clinic
This is for the student’s contracted rate
Salaries for therapists (in-kind donation from clinics), $28/hr. for 20 therapists
for 1 hour

560

Marketing and Advertising

30

Fliers for project proposal ($30), 5-dollar coffee cards for participants ($100)
Facility Expense

450

Room expense, utilities at the 3 clinics to present educational sessions, 3 hours
per facility at $50 for each hour (estimated by clinic owners, in-kind donation
from clinics)

Total $5975

Operating Income $-240
*Noted that this is a negative value (operating loss). Anticipate grant funding in
subsequent years to change the value to a positive figure
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Appendix M
Table M1
Scholarly Project 3-5 Year Budget Plan

Budget
Year 1

Budget
Year 2

Budge
t Year
3

Budge
t Year
4

Budge
t Year
5

5060

0

0

0

0

Grant Cycle Year 2 and 3

2500

0

0

0

Grant Cycle Year 4 and 5

0

2500

2500

2500

5735

2500

2500

2500

2500

450

450

450

450

450

2475

2475

2475

2475

2475

150

150

150

150

150

60

60

60

60

60

2250

2317

2386

2457

2530

Revenues

In-kind student donations

Total
Expenses
Facility Expense
Room expense, utilities at the 3 clinics to present
educational sessions, 3 hours per facility at $50
for each hour (estimated by clinic owners, inkind donation from clinics)

Evaluation and Assessment
Costs for student’s time (in-kind) for preparation
of evaluation, analyses of surveys, administration
time to process results for dissemination, $75/hr.
for 11 hours at 3 clinics

Administrative Supplies
Printer cartridges, printer, paper, copying, pens,
phone services
Educational material, laminated resources,
training material, surveys
Travel Expenses
Costs to travel to and from offices

Educational Initial Training
Salaries for the student (in-kind student donated
hours), $75/hr. for 10 hours per clinic
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This is for the student’s contracted rate (average
3.22% inflation per year)

560

576

593

610

628

30

30

30

30

30

5975

6058

6144

6232

240

2883

2969

3057

Salaries for therapists (first year only in-kind
donation from clinics), $28/hr. for 20 therapists
for 1 hour

Marketing and Advertising
Fliers for project proposal
Total

Operating Income

6323

3148
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Appendix N
Table N1
Demographics
Mean

SD

Years of experience

10.35294118

5.851721717

Level of Discipline

2.941176471

0.826936231

Title Level

1.411764706

0.507299656

Table N2
Run Charts for Referrals

Clinic 2 Clinician Referrals

Clinic 2

15
15

10

10
5

5

0

0
March April

May

June

July August

March April

Clinic 1 Clincian Referrals
25
20
15
10
5
0

Clinic 1
30
20
10
0

March April May

June

July August

May

June

July August
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Clinic 3
10

Clinic 3 Referrals

10
5

5
0

0
March April

May

June

July August

March April

Resource use
8
7
6
5
4
3
2
1
0
May

June

July

August

May

June

July August
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Table N3
Statement of Beliefs, Knowledge, and Confidence

Statement

Baseline
M (SD)

Time 1
Post Test
M (SD)

Time 2
Post Test
M (SD)

t test
Time 1vs2
Time 2vs3

Beliefs
I believe clinicians should have a working knowledge of psychopharmacology to
improve effective treatment planning

1.4 (0.50)

1.2 (0.42)

1.0 (0.23)

1.37
1.84 **

I believe a working knowledge of psychopharmacology can increase therapeutic
effectiveness
I believe medications can be an effective way to treat mental health disorders

1.2 (0.61)

1.3 0(.59)

1.2 (0.42)

1.2 (0.62)

1.5 (0.61)

1.2 (0.46)

I believe clinicians have a lack of knowledge of medications used in the treatment of
mental health disorders
I believe that patients can overcome mental illness without the use of medications

2 (0.61)

2.1 (0.90)

1.6 (0.68)

2.2 (0.68)

2 (0.50)

2.2 (0.83))

I believe basic psychopharmacology literacy is part of my responsibility

1.6 (0.61)

1.4 (0.50)

1.2 (0.043)

1.75
1.45
0.00
1.79
-0.56
2.56 **
1.3
-1.07
1.73
1.3

I have an understanding of the medications most commonly used to treat mental
disorders and know that mental health symptoms can be mimicked by other medical
causes
I have an understanding of symptoms caused by mental disorder medications

2.4 (0.71)

1.6 (0.48)

1.4 (0.51)

4.19 **
1.45

2.4 (0.71)

1.8 (0.75)

1.5 (0.61)

I understand the medications my patients are taking

2.8 (1.0)

2.1 (0.83)

1.7 (0.73)

I have the knowledge of medications that are used to treat sleep

2 (0.70)

1.7 (0.66)

1.7 (0.73)

I have the knowledge of medications that are used to treat anxiety

2.2 (0.46)

1.7 (0.66)

1.6 (0.68)

I have the knowledge of medications that are used to treat depression

2.5 (0.42)

1.6 (0.68)

1.6 (0.69)

I have the knowledge of medications that are used to treat bipolar disorder

2.7 (0.77)

1.7 (0.73)

1.7 (0.66)

I have the knowledge of medications that are used to treat
schizophrenia/schizoaffective disorder
I have the knowledge of medications that are used to treat ADHD

2.5 (1.0)

1.7 (0.64)

1.7 (0.64)

2.3 (0.75)

1.7 (0.66)

1.7 (0.66)

2.52 **
2.91 **
2.40 **
2.91 **
1.5
-1
2.78 **
1
2.38 **
1
3.39 **
0.23
4.19 **
4.00 **
2.21 **
2.00 **

Intentions/Confidence
I use evidence-based referral practices

1.7 (0.43)

1.4 (0.51)

1.1 (0.32)

I have confidence in discussing basic medication management with my patients

2.4 (0.79)

1.7 (0.54)

1.7 (0.57)

I feel confident reinforcing medication management recommendations

2 (0.95)

1.6 (0.76)

1.4 (0.51)

I feel comfortable consulting with medication management providers if I have
questions about medications
I have a resource for psychopharmacology questions

1.5 (0.61)

1.2 (0.42)

1.2 (0.42)

2.0 (1.1)

1.1 (0.38)

1.2 (0.54)

Knowledge

2.58 **
2.91 **
2.63 **
1
1.92 **
1.71
2.40 **
0
2.98 **
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I feel well prepared in psychopharmacology

3.1 (0.80)

2.2 (0.80)

1.9 (0.53)

I have the skills to discuss basic psychopharmacology with patients

2.7 (0.84)

1.6 (0.48)

1.6 (0.48)

I know whom to contact with questions

1.7 (0.58)

1.2 (0.46)

1.1 (0.32)

**p<0.05

Table N4
Time Comparisons
Should have working knowledge
time one
time two
time three
1.411764706 1.222222222 1.055555556
0.507299656 0.427792632 0.23570226

Working knowledge
3
2
1
0

0.5

1

1.5
SD

2

2.5

3

Means

Working knowledge
+effectiveness
1.229847495 1.333333333 1.222222222
0.618346942 0.594088526 0.427792632

Knowledge effectivness
3
2
1
0

0.5

1

1.5
SD

Means

2

2.5

3

-0.32
4.51 **
1.42
4.51 **
0
2.42 **
1.3
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Medications effective
1.245824256
0.624264273

1.5 1.277777778
0.618346942 0.460888599

Medication effectivness
3
2
1
0

0.5

1

1.5
SD

2

2.5

3

Means

Lack of
knowledge
2 2.111111111 1.666666667
0.612372436 0.90025414 0.685994341

Lack of knowledge
3
2
1
0

0.5

1

1.5
SD

2

2.5

3

Means

Overcome illness
2.25
0.683130051

2
0.5

2.235294118
0.831370237

Overcome Illness
3
2
1
0

0.5

1

1.5
SD

med literacy

Means

2

2.5

3
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1.625 1.411764706 1.235294118
0.619139187 0.507299656 0.437237316

Med Literacy
3
2
1
0

0.5

1

1.5
SD

2

2.5

3

Means

Mimic
time one
time two
time three
2.470588235 1.666666667 1.444444444
0.717430054 0.48507125 0.511309993

Mental illness mimicks
3
2
1
0

0.5

1

1.5
SD

2

2.5

3

Means

Understand
sx
2.470588235 1.888888889 1.555555556
0.717430054 0.758395279 0.615698763

Understand sx
3
2
1
0

0.5

1

1.5
SD

Means

2

2.5

3
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Understand meds
2.823529412 2.111111111 1.777777778
1.014599312 0.832352364 0.732084498

Understand meds
3
2
1
0

0.5

1

1.5
SD

2

2.5

3

Means

sleep
2 1.722222222 1.777777778
0.707106781 0.669113158 0.732084498

Sleep meds
3
2
1
0

0.5

1

1.5
SD

2

2.5

3

Means

anxiety
2.294117647 1.722222222 1.666666667
0.469668218 0.669113158 0.685994341

Anxiety
3
2
1
0

0.5

1

1.5
SD

2

2.5

3

Means

depression
2.058823529 1.666666667 1.611111111
0.428746463 0.685994341 0.697802339
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Depression
3
2
1
0

0.5

1

1.5
SD

2

2.5

3

Means

bipolar
2.705882353 1.777777778 1.722222222
0.771743633 0.732084498 0.669113158

Bipolar
3
2
1
0

0.5

1

1.5
SD

2

2.5

3

Means

schizo
2.588235294 1.777777778 1.777777778
1.003669737 0.646761667 0.646761667

Schizo
3
2
1
0

0.5

1
SD

1.5

2

2.5

3

Means

ADHD
2.235294118 1.722222222 1.722222222
0.752446989 0.669113158 0.669113158
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ADHD
3
2
1
0

0.5

1

1.5
SD

2

Means

2.5

3

